FDA seeks more data on Acura's abuse-resistant pain drug
August 15, 2014 at 07:32 AM EDT
Aug 15 (Reuters) - Acura Pharmaceuticals Inc said the U.S. Food and Drug Administration (FDA) indicated that the company may have to conduct an additional study to determine the abuse-deterrent capability of its experimental painkiller treatment.
